Literature DB >> 18602262

Biphenyl amide p38 kinase inhibitors 4: DFG-in and DFG-out binding modes.

Richard M Angell1, Tony D Angell, Paul Bamborough, Mark J Bamford, Chun-wa Chung, Stuart G Cockerill, Stephen S Flack, Katherine L Jones, Dramane I Laine, Timothy Longstaff, Steve Ludbrook, Rosannah Pearson, Kathryn J Smith, Penny A Smee, Don O Somers, Ann L Walker.   

Abstract

The biphenyl amides (BPAs) are a series of p38alpha MAP kinase inhibitors. Compounds are able to bind to the kinase in either the DFG-in or DFG-out conformation, depending on substituents. X-ray, binding, kinetic and cellular data are shown, providing the most detailed comparison to date between potent compounds from the same chemical series that bind to different p38alpha conformations. DFG-out-binding compounds could be made more potent than DFG-in-binding compounds by increasing their size. Unexpectedly, compounds that bound to the DGF-out conformation showed diminished selectivity. The kinetics of binding to the isolated enzyme and the effects of compounds on cells were largely unaffected by the kinase conformation bound.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18602262     DOI: 10.1016/j.bmcl.2008.06.028

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  14 in total

Review 1.  p38(MAPK): stress responses from molecular mechanisms to therapeutics.

Authors:  Lydia R Coulthard; Danielle E White; Dominic L Jones; Michael F McDermott; Susan A Burchill
Journal:  Trends Mol Med       Date:  2009-08-06       Impact factor: 11.951

2.  Affinity reagents that target a specific inactive form of protein kinases.

Authors:  Pratistha Ranjitkar; Amanda M Brock; Dustin J Maly
Journal:  Chem Biol       Date:  2010-02-26

3.  Insights from free-energy calculations: protein conformational equilibrium, driving forces, and ligand-binding modes.

Authors:  Yu-Ming M Huang; Wei Chen; Michael J Potter; Chia-En A Chang
Journal:  Biophys J       Date:  2012-07-17       Impact factor: 4.033

4.  A novel mechanism by which small molecule inhibitors induce the DFG flip in Aurora A.

Authors:  Mathew P Martin; Jin-Yi Zhu; Harshani R Lawrence; Roberta Pireddu; Yunting Luo; Riazul Alam; Sevil Ozcan; Said M Sebti; Nicholas J Lawrence; Ernst Schönbrunn
Journal:  ACS Chem Biol       Date:  2012-01-27       Impact factor: 5.100

5.  Sequence determinants of a specific inactive protein kinase conformation.

Authors:  Sanjay B Hari; Ethan A Merritt; Dustin J Maly
Journal:  Chem Biol       Date:  2013-06-20

6.  A novel approach to the discovery of small-molecule ligands of CDK2.

Authors:  Mathew P Martin; Riazul Alam; Stephane Betzi; Donna J Ingles; Jin-Yi Zhu; Ernst Schönbrunn
Journal:  Chembiochem       Date:  2012-08-14       Impact factor: 3.164

7.  3D-QSAR and molecular docking analysis of biphenyl amide derivatives as p38α mitogen-activated protein kinase inhibitors.

Authors:  Pravin Sundarao Ambure; Rahul Prakashchand Gangwal; Abhay T Sangamwar
Journal:  Mol Divers       Date:  2012-01-07       Impact factor: 2.943

8.  Coupling of receptor conformation and ligand orientation determine graded activity.

Authors:  John B Bruning; Alexander A Parent; German Gil; Min Zhao; Jason Nowak; Margaret C Pace; Carolyn L Smith; Pavel V Afonine; Paul D Adams; John A Katzenellenbogen; Kendall W Nettles
Journal:  Nat Chem Biol       Date:  2010-10-10       Impact factor: 15.040

9.  First comprehensive structural and biophysical analysis of MAPK13 inhibitors targeting DFG-in and DFG-out binding modes.

Authors:  Zeynep Yurtsever; Dhara A Patel; Daniel L Kober; Alvin Su; Chantel A Miller; Arthur G Romero; Michael J Holtzman; Tom J Brett
Journal:  Biochim Biophys Acta       Date:  2016-06-29

10.  Conformation-selective inhibitors reveal differences in the activation and phosphate-binding loops of the tyrosine kinases Abl and Src.

Authors:  Sanjay B Hari; B Gayani K Perera; Pratistha Ranjitkar; Markus A Seeliger; Dustin J Maly
Journal:  ACS Chem Biol       Date:  2013-10-29       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.